Moreover, if the phenotype we demonstrate is common and CXCR7 signaling causes degradation of Rb in tumor cells in other cancer systems, the inhibition of CXCR7 could be a powerful target for the treatment of malignant cellular proliferation in general. This evidence concerns the gene RB1 and neoplasm.